Einhorn Andrew J. bought PTHS
December 23, 2025 · Form 4 insider transaction
Einhorn Andrew J. bought 12,000 shares of Pelthos Therapeutics Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
N/A
Total value
N/A
InsiderEinhorn Andrew J.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 23, 2025
Filing dateDecember 29, 2025
Shares owned after12,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On December 23, 2025, the Reporting Person was granted 12,000 Restricted Stock Units (the "RSUs") of the issuer, as compensation for the Reporting Person's service as a member of the issuer's board of directors, pursuant to the issuer's 2023 Equity Incentive Plan, as amended and restated effective as of April 16, 2025 (the "Plan"). The RSUs will vest on January 1, 2027. Each RSU represents a contingent right to receive one share of issuer's Common Stock, par value $0.0001 per share.